South Florida Hospital News
Thursday February 25, 2021

test 2

July 2004 - Volume 1 - Issue 1


International Symposium on Hyperbaric Oxygen Therapy Offers Cutting Edge Forums and Ideas For Brain Injury

Gracie is a 5 year old with an extremely rare genetic disorder: Mitochondrial cytochrome c reductase. At the time of Grace’s diagnosis, there were only 5 other cases of this disease cited worldwide, and the life expectancy for the children born with this condition was virtually zero. In the four other cases reported, the children died as infants (less than 15 months of age). Grace is alive and thriving.

What makes Grace so special, medically speaking?

Hyperbaric Oxygen Therapy (HBOT). Grace is the first mitochondrial cytochrome c reductase patient known to have received hyperbaric oxygenation as a treatment for this disease.

Since beginning hyperbaric oxygenation therapy, Grace has gone from a non-responsive, vegetative state – legally blind (optic atrophy), prone to seizures (even with medication), G-Tube dependent, hypotonic, speechless, unable to crawl, unable to sit up, lacking in both fine and gross motor skills, unable to feel and cognitively deficient – to now qualifying to start kindergarten in the fall.

Today, after 384 Hyperbaric Oxygen Treatments, Grace is a modern miracle of Hyperbaric Medicine. Neurologist, Richard Neubauer, M.D., from the Ocean Neurologic Center, began treating Grace upon recommendation by Grace’s pediatrician, Raul Ponte, M.D. Dr. Ponte saw only a grim prognosis for Grace if she continued traditional medical care alone. Thus, Drs. Neubauer and Ponte went against conventional medical practice and colleagues – and with good reason.

Dr. Neubauer accepted Grace for therapy on the premise that hyperbaric oxygenation is known to increase the oxygen in the mitochondria and has been known to have a positive effect on cytochrome c in severe carbon monoxide intoxication. It is important to note that the cytochrome c reductase deficiency occurs between step III and IV at the cross-fertilization cycle concerning electron transfer and actual cellular exploration.

Grace’s dramatic improvement – measured by SPECT brain scans, muscle biopsies (which now show no evidence of cytochrome c reductase deficiency or abnormalities in the enzymes), and visible changes seen physically and mentally – make the case for hyperbaric oxygenation. Grace can now see, eat and feel normally. She maintains a healthy weight, has learned to crawl and now walks with the help of a walker.

Because Grace spent a year and a half of her life in hospitals – at a cost of $10 million dollars – the family went into financial debt. Hyperbaric Oxygenation has changed the increasing cycle of debt. Grace no longer requires frequent hospitalization and costly medicines she once required for seizures, reflux and mitochondrial patterns. Coinciding with the number of Hyperbaric Oxygen Therapies, these medicines have now been tapered off. The cost of the intense vitamin program, which her system required prior to hyperbarics, was $4000.00 a month. Her body is now able to maintain healthy vitamin levels through oral consumption of regular foods.

Since first treating Grace, Dr. Neubauer has begun treating six other children with mitochondrial conditions using hyperbaric oxygen therapy, with similar positive results.

4th International Symposium on Hyperbaric Oxygen Therapy Set For July 28-31

Dr. Neubauer’s findings on the treatment of mitochondrial cytochrome c reductase with Hyperbaric Oxygenation will be presented at the ‘4th International Symposium on CP and the Brain-Injured Child’, July 28-31, 2004 in Fort Lauderdale, Florida.

Each year, The International Symposium on Hyperbaric Oxygen Therapy brings forward new, cutting-edge forums and scientific ideas that impact children living with cerebral palsy and brain injury. In addition, the symposium serves as an interactive media for doctors, legislators and patients, and focuses on alternative medicine and the future of Hyperbarics around the world. In a special forum investigating Genetics and Hyperbaric Oxygenation, Dr. Neubauer will provide documentation for this modality of treatment in 7 cases of mitochondrial disorder patients.

Demonstrating the success of treating neurological conditions with Hyperbaric Oxygenation, world-renowned neurological and hyperbaric physicians and experts will present and discuss the latest research that is being conducted. Their findings have altered the course of medical practice for brain injury.

It is the goal of the Symposium to continue to educate physicians, therapist, caregivers and parents about advanced treatments that not only complement hyperbaric oxygen therapy, but that also impact the lives of children with various neurological injuries.

Over 15,000 children worldwide have been treated with Hyperbaric Oxygenation, with an almost a 90% improvement rate, and the percentage affected each year grows!

For more information on this symposium, or to register, please call (954) 771-4000. The symposium will be held at the famous Hyatt Regency Pier Sixty-Six in Fort Lauderdale, FL.
Share |